Literature DB >> 7161607

Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid.

C J Sindic, M P Chalon, C L Cambiaso, E C Laterre, P L Masson.   

Abstract

S-100 protein was determined by Particle Counting ImmunoAssay in the CSF of patients with various neurological disorders. With a limit of sensitivity of 2.5 micrograms/l this brain-specific protein was detected only in samples from patients with acute damage of the central nervous system, particularly in compression of the spinal cord by tumour, ischaemic disorders, subarachnoïd bleeding and haematoma, and viral or suspected viral infections. Our results support the assumption that S-100 is a reliable index of central nervous system damage and that changes in its concentration could have a prognostic value.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7161607      PMCID： PMC491696          DOI： 10.1136/jnnp.45.12.1130

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  35 in total

1.  Immunochemical properties of S-100 proteins and their subunits.

Authors:  S P Mahadik; L Graf; A Korenovsky; M M Rapport
Journal:  J Neurochem       Date:  1979-09       Impact factor: 5.372

2.  Particle counting immunoassay (PACIA). I. A general method for the determination of antibodies, antigens, and haptens.

Authors:  C L Cambiaso; A E Leek; F De Steenwinkel; J Billen; P L Masson
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

3.  Particle counting immunoassay. IV. The use of F(ab')2 fragments and N epsilon-chloroacetyl lysine N-carboxyanhydride for their coupling to polystyrene latex particles.

Authors:  J N Limet; C H Moussebois; C L Cambiaso; J P Vaerman; P L Masson
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

4.  The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients.

Authors:  F Michetti; A Massaro; M Murazio
Journal:  Neurosci Lett       Date:  1979-02       Impact factor: 3.046

5.  A soluble protein characteristic of the nervous system.

Authors:  B W Moore
Journal:  Biochem Biophys Res Commun       Date:  1965-06-09       Impact factor: 3.575

6.  The amino-acid sequence of S-100 protein (PAP I-b protein) and its relation to the calcium-binding proteins.

Authors:  T Isobe; T Okuyama
Journal:  Eur J Biochem       Date:  1978-09-01

7.  S100 protein in folliculostellate cells of the rat pituitary anterior lobe.

Authors:  T Nakajima; H Yamaguchi; K Takahashi
Journal:  Brain Res       Date:  1980-06-09       Impact factor: 3.252

8.  Heterogeneity of S-100 proteins of brain: subunit compositions.

Authors:  S P Mahadik; A Korenovsky; M M Rapport
Journal:  J Neurochem       Date:  1979-09       Impact factor: 5.372

9.  Immunohistochemical demonstration of S-100 protein and GFA protein in interstitial cells of rat pineal gland.

Authors:  M Møller; A Ingild; E Bock
Journal:  Brain Res       Date:  1978-01-20       Impact factor: 3.252

10.  The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system.

Authors:  F Michetti; A Massaro; G Russo; G Rigon
Journal:  J Neurol Sci       Date:  1980-01       Impact factor: 3.181
View more
  13 in total

1.  Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  P J Jongen; K J Lamers; W H Doesburg; W A Lemmens; O R Hommes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

Review 2.  Cerebrospinal fluid markers in neurological disorders.

Authors:  A R Massaro; G Scivoletto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1990-12

3.  Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy.

Authors:  E S Connolly; C J Winfree; A Rampersad; R Sharma; W J Mack; J Mocco; R A Solomon; G Todd; D O Quest; Y Stern; E J Heyer
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

4.  S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction.

Authors:  H G Hårdemark; O Almqvist; T Johansson; S Påhlman; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value?

Authors:  T Ingebrigtsen; B Romner; P Kongstad; B Langbakk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

6.  Clinico-pathophysiological features of acute autonomic and sensory neuropathy: a long-term follow-up study.

Authors:  T Yasuda; G Sobue; K Mokuno; S Hakusui; T Ito; Y Hirose; T Yanagi
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

7.  Elevated levels of the alpha subunit of GTP-binding protein Go in cerebrospinal fluid of patients with neurological disorders.

Authors:  T Murayama; A Takahashi; T Asano; K Kato
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

8.  Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients.

Authors:  J de Vries; W A Thijssen; S E Snels; T Menovsky; N G Peer; K J Lamers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

9.  Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.

Authors:  Anna Grahn; Lars Hagberg; Staffan Nilsson; Kaj Blennow; Henrik Zetterberg; Marie Studahl
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

10.  S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage.

Authors:  L Persson; H Hårdemark; G Edner; E Ronne; I Mendel-Hartvig; S Påhlman
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.